Global Cell and Gene Therapy Manufacturing Services Market Research Report 2024, Forecast to 2032

October 2024 | 178 pages | ID: G0B57F5AF9CDEN
Bosson Research

Abstracts

Report Overview

Gene therapy aims to treat disorders by replacing or introducing genes into cells— either inside the body (in vivo) or outside of the body (ex vivo).

The global Cell and Gene Therapy Manufacturing Services market size was estimated at USD 4729.80 million in 2023 and is projected to reach USD 10188.11 million by 2032, exhibiting a CAGR of 8.90% during the forecast period.

North America Cell and Gene Therapy Manufacturing Services market size was estimated at USD 1427.66 million in 2023, at a CAGR of 7.63% during the forecast period of 2024 through 2032.

This report provides a deep insight into the global Cell and Gene Therapy Manufacturing Services market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Cell and Gene Therapy Manufacturing Services Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Cell and Gene Therapy Manufacturing Services market in any manner.

Global Cell and Gene Therapy Manufacturing Services Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Thermo Fisher Scientific

Merck KGaA

Charles River Laboratories

Lonza

Catalent

WuXi AppTec

Takara Bio Inc

Nikon Corporation

FUJIFILM Holdings Corporation

F. Hoffmann-La Roche

Oxford Biomedica Plc

Cell and Gene Therapy Catapult

The Discovery Labs LLC

RoslinCT

JRS PHARMA

FinVector

ABL

Resilience

BioCentriq

Porton Biopharma Limited

Andelyn Biosciences

Commercializing Living Therapies

Vibalogics

Anemocyte Srl

ElevateBio

Market Segmentation (by Type)

Allogeneic

Autologous

Viral Vector

Market Segmentation (by Application)

Oncology Diseases

Cardiovascular Diseases

Orthopedic Diseases

Ophthalmology Diseases

Infectious Diseases

Others

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Cell and Gene Therapy Manufacturing Services Market
• Overview of the regional outlook of the Cell and Gene Therapy Manufacturing Services Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Cell and Gene Therapy Manufacturing Services Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Cell and Gene Therapy Manufacturing Services, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.

Chapter 13 is the main points and conclusions of the report.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Cell and Gene Therapy Manufacturing Services
1.2 Key Market Segments
  1.2.1 Cell and Gene Therapy Manufacturing Services Segment by Type
  1.2.2 Cell and Gene Therapy Manufacturing Services Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Cell and Gene Therapy Manufacturing Services Market Size (M USD) Estimates and Forecasts (2019-2032)
  2.1.2 Global Cell and Gene Therapy Manufacturing Services Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET COMPETITIVE LANDSCAPE

3.1 Global Cell and Gene Therapy Manufacturing Services Sales by Manufacturers (2019-2024)
3.2 Global Cell and Gene Therapy Manufacturing Services Revenue Market Share by Manufacturers (2019-2024)
3.3 Cell and Gene Therapy Manufacturing Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Cell and Gene Therapy Manufacturing Services Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Cell and Gene Therapy Manufacturing Services Sales Sites, Area Served, Product Type
3.6 Cell and Gene Therapy Manufacturing Services Market Competitive Situation and Trends
  3.6.1 Cell and Gene Therapy Manufacturing Services Market Concentration Rate
  3.6.2 Global 5 and 10 Largest Cell and Gene Therapy Manufacturing Services Players Market Share by Revenue
  3.6.3 Mergers & Acquisitions, Expansion

4 CELL AND GENE THERAPY MANUFACTURING SERVICES INDUSTRY CHAIN ANALYSIS

4.1 Cell and Gene Therapy Manufacturing Services Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
  5.5.1 New Product Developments
  5.5.2 Mergers & Acquisitions
  5.5.3 Expansions
  5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies

6 CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Cell and Gene Therapy Manufacturing Services Sales Market Share by Type (2019-2024)
6.3 Global Cell and Gene Therapy Manufacturing Services Market Size Market Share by Type (2019-2024)
6.4 Global Cell and Gene Therapy Manufacturing Services Price by Type (2019-2024)

7 CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Cell and Gene Therapy Manufacturing Services Market Sales by Application (2019-2024)
7.3 Global Cell and Gene Therapy Manufacturing Services Market Size (M USD) by Application (2019-2024)
7.4 Global Cell and Gene Therapy Manufacturing Services Sales Growth Rate by Application (2019-2024)

8 CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET CONSUMPTION BY REGION

8.1 Global Cell and Gene Therapy Manufacturing Services Sales by Region
  8.1.1 Global Cell and Gene Therapy Manufacturing Services Sales by Region
  8.1.2 Global Cell and Gene Therapy Manufacturing Services Sales Market Share by Region
8.2 North America
  8.2.1 North America Cell and Gene Therapy Manufacturing Services Sales by Country
  8.2.2 U.S.
  8.2.3 Canada
  8.2.4 Mexico
8.3 Europe
  8.3.1 Europe Cell and Gene Therapy Manufacturing Services Sales by Country
  8.3.2 Germany
  8.3.3 France
  8.3.4 U.K.
  8.3.5 Italy
  8.3.6 Russia
8.4 Asia Pacific
  8.4.1 Asia Pacific Cell and Gene Therapy Manufacturing Services Sales by Region
  8.4.2 China
  8.4.3 Japan
  8.4.4 South Korea
  8.4.5 India
  8.4.6 Southeast Asia
8.5 South America
  8.5.1 South America Cell and Gene Therapy Manufacturing Services Sales by Country
  8.5.2 Brazil
  8.5.3 Argentina
  8.5.4 Columbia
8.6 Middle East and Africa
  8.6.1 Middle East and Africa Cell and Gene Therapy Manufacturing Services Sales by Region
  8.6.2 Saudi Arabia
  8.6.3 UAE
  8.6.4 Egypt
  8.6.5 Nigeria
  8.6.6 South Africa

9 CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET PRODUCTION BY REGION

9.1 Global Production of Cell and Gene Therapy Manufacturing Services by Region (2019-2024)
9.2 Global Cell and Gene Therapy Manufacturing Services Revenue Market Share by Region (2019-2024)
9.3 Global Cell and Gene Therapy Manufacturing Services Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Cell and Gene Therapy Manufacturing Services Production
  9.4.1 North America Cell and Gene Therapy Manufacturing Services Production Growth Rate (2019-2024)
  9.4.2 North America Cell and Gene Therapy Manufacturing Services Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Cell and Gene Therapy Manufacturing Services Production
  9.5.1 Europe Cell and Gene Therapy Manufacturing Services Production Growth Rate (2019-2024)
  9.5.2 Europe Cell and Gene Therapy Manufacturing Services Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Cell and Gene Therapy Manufacturing Services Production (2019-2024)
  9.6.1 Japan Cell and Gene Therapy Manufacturing Services Production Growth Rate (2019-2024)
  9.6.2 Japan Cell and Gene Therapy Manufacturing Services Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Cell and Gene Therapy Manufacturing Services Production (2019-2024)
  9.7.1 China Cell and Gene Therapy Manufacturing Services Production Growth Rate (2019-2024)
  9.7.2 China Cell and Gene Therapy Manufacturing Services Production, Revenue, Price and Gross Margin (2019-2024)

10 KEY COMPANIES PROFILE

10.1 Thermo Fisher Scientific
  10.1.1 Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services Basic Information
  10.1.2 Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services Product Overview
  10.1.3 Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services Product Market Performance
  10.1.4 Thermo Fisher Scientific Business Overview
  10.1.5 Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services SWOT Analysis
  10.1.6 Thermo Fisher Scientific Recent Developments
10.2 Merck KGaA
  10.2.1 Merck KGaA Cell and Gene Therapy Manufacturing Services Basic Information
  10.2.2 Merck KGaA Cell and Gene Therapy Manufacturing Services Product Overview
  10.2.3 Merck KGaA Cell and Gene Therapy Manufacturing Services Product Market Performance
  10.2.4 Merck KGaA Business Overview
  10.2.5 Merck KGaA Cell and Gene Therapy Manufacturing Services SWOT Analysis
  10.2.6 Merck KGaA Recent Developments
10.3 Charles River Laboratories
  10.3.1 Charles River Laboratories Cell and Gene Therapy Manufacturing Services Basic Information
  10.3.2 Charles River Laboratories Cell and Gene Therapy Manufacturing Services Product Overview
  10.3.3 Charles River Laboratories Cell and Gene Therapy Manufacturing Services Product Market Performance
  10.3.4 Charles River Laboratories Cell and Gene Therapy Manufacturing Services SWOT Analysis
  10.3.5 Charles River Laboratories Business Overview
  10.3.6 Charles River Laboratories Recent Developments
10.4 Lonza
  10.4.1 Lonza Cell and Gene Therapy Manufacturing Services Basic Information
  10.4.2 Lonza Cell and Gene Therapy Manufacturing Services Product Overview
  10.4.3 Lonza Cell and Gene Therapy Manufacturing Services Product Market Performance
  10.4.4 Lonza Business Overview
  10.4.5 Lonza Recent Developments
10.5 Catalent
  10.5.1 Catalent Cell and Gene Therapy Manufacturing Services Basic Information
  10.5.2 Catalent Cell and Gene Therapy Manufacturing Services Product Overview
  10.5.3 Catalent Cell and Gene Therapy Manufacturing Services Product Market Performance
  10.5.4 Catalent Business Overview
  10.5.5 Catalent Recent Developments
10.6 WuXi AppTec
  10.6.1 WuXi AppTec Cell and Gene Therapy Manufacturing Services Basic Information
  10.6.2 WuXi AppTec Cell and Gene Therapy Manufacturing Services Product Overview
  10.6.3 WuXi AppTec Cell and Gene Therapy Manufacturing Services Product Market Performance
  10.6.4 WuXi AppTec Business Overview
  10.6.5 WuXi AppTec Recent Developments
10.7 Takara Bio Inc
  10.7.1 Takara Bio Inc Cell and Gene Therapy Manufacturing Services Basic Information
  10.7.2 Takara Bio Inc Cell and Gene Therapy Manufacturing Services Product Overview
  10.7.3 Takara Bio Inc Cell and Gene Therapy Manufacturing Services Product Market Performance
  10.7.4 Takara Bio Inc Business Overview
  10.7.5 Takara Bio Inc Recent Developments
10.8 Nikon Corporation
  10.8.1 Nikon Corporation Cell and Gene Therapy Manufacturing Services Basic Information
  10.8.2 Nikon Corporation Cell and Gene Therapy Manufacturing Services Product Overview
  10.8.3 Nikon Corporation Cell and Gene Therapy Manufacturing Services Product Market Performance
  10.8.4 Nikon Corporation Business Overview
  10.8.5 Nikon Corporation Recent Developments
10.9 FUJIFILM Holdings Corporation
  10.9.1 FUJIFILM Holdings Corporation Cell and Gene Therapy Manufacturing Services Basic Information
  10.9.2 FUJIFILM Holdings Corporation Cell and Gene Therapy Manufacturing Services Product Overview
  10.9.3 FUJIFILM Holdings Corporation Cell and Gene Therapy Manufacturing Services Product Market Performance
  10.9.4 FUJIFILM Holdings Corporation Business Overview
  10.9.5 FUJIFILM Holdings Corporation Recent Developments
10.10 F. Hoffmann-La Roche
  10.10.1 F. Hoffmann-La Roche Cell and Gene Therapy Manufacturing Services Basic Information
  10.10.2 F. Hoffmann-La Roche Cell and Gene Therapy Manufacturing Services Product Overview
  10.10.3 F. Hoffmann-La Roche Cell and Gene Therapy Manufacturing Services Product Market Performance
  10.10.4 F. Hoffmann-La Roche Business Overview
  10.10.5 F. Hoffmann-La Roche Recent Developments
10.11 Oxford Biomedica Plc
  10.11.1 Oxford Biomedica Plc Cell and Gene Therapy Manufacturing Services Basic Information
  10.11.2 Oxford Biomedica Plc Cell and Gene Therapy Manufacturing Services Product Overview
  10.11.3 Oxford Biomedica Plc Cell and Gene Therapy Manufacturing Services Product Market Performance
  10.11.4 Oxford Biomedica Plc Business Overview
  10.11.5 Oxford Biomedica Plc Recent Developments
10.12 Cell and Gene Therapy Catapult
  10.12.1 Cell and Gene Therapy Catapult Cell and Gene Therapy Manufacturing Services Basic Information
  10.12.2 Cell and Gene Therapy Catapult Cell and Gene Therapy Manufacturing Services Product Overview
  10.12.3 Cell and Gene Therapy Catapult Cell and Gene Therapy Manufacturing Services Product Market Performance
  10.12.4 Cell and Gene Therapy Catapult Business Overview
  10.12.5 Cell and Gene Therapy Catapult Recent Developments
10.13 The Discovery Labs LLC
  10.13.1 The Discovery Labs LLC Cell and Gene Therapy Manufacturing Services Basic Information
  10.13.2 The Discovery Labs LLC Cell and Gene Therapy Manufacturing Services Product Overview
  10.13.3 The Discovery Labs LLC Cell and Gene Therapy Manufacturing Services Product Market Performance
  10.13.4 The Discovery Labs LLC Business Overview
  10.13.5 The Discovery Labs LLC Recent Developments
10.14 RoslinCT
  10.14.1 RoslinCT Cell and Gene Therapy Manufacturing Services Basic Information
  10.14.2 RoslinCT Cell and Gene Therapy Manufacturing Services Product Overview
  10.14.3 RoslinCT Cell and Gene Therapy Manufacturing Services Product Market Performance
  10.14.4 RoslinCT Business Overview
  10.14.5 RoslinCT Recent Developments
10.15 JRS PHARMA
  10.15.1 JRS PHARMA Cell and Gene Therapy Manufacturing Services Basic Information
  10.15.2 JRS PHARMA Cell and Gene Therapy Manufacturing Services Product Overview
  10.15.3 JRS PHARMA Cell and Gene Therapy Manufacturing Services Product Market Performance
  10.15.4 JRS PHARMA Business Overview
  10.15.5 JRS PHARMA Recent Developments
10.16 FinVector
  10.16.1 FinVector Cell and Gene Therapy Manufacturing Services Basic Information
  10.16.2 FinVector Cell and Gene Therapy Manufacturing Services Product Overview
  10.16.3 FinVector Cell and Gene Therapy Manufacturing Services Product Market Performance
  10.16.4 FinVector Business Overview
  10.16.5 FinVector Recent Developments
10.17 ABL
  10.17.1 ABL Cell and Gene Therapy Manufacturing Services Basic Information
  10.17.2 ABL Cell and Gene Therapy Manufacturing Services Product Overview
  10.17.3 ABL Cell and Gene Therapy Manufacturing Services Product Market Performance
  10.17.4 ABL Business Overview
  10.17.5 ABL Recent Developments
10.18 Resilience
  10.18.1 Resilience Cell and Gene Therapy Manufacturing Services Basic Information
  10.18.2 Resilience Cell and Gene Therapy Manufacturing Services Product Overview
  10.18.3 Resilience Cell and Gene Therapy Manufacturing Services Product Market Performance
  10.18.4 Resilience Business Overview
  10.18.5 Resilience Recent Developments
10.19 BioCentriq
  10.19.1 BioCentriq Cell and Gene Therapy Manufacturing Services Basic Information
  10.19.2 BioCentriq Cell and Gene Therapy Manufacturing Services Product Overview
  10.19.3 BioCentriq Cell and Gene Therapy Manufacturing Services Product Market Performance
  10.19.4 BioCentriq Business Overview
  10.19.5 BioCentriq Recent Developments
10.20 Porton Biopharma Limited
  10.20.1 Porton Biopharma Limited Cell and Gene Therapy Manufacturing Services Basic Information
  10.20.2 Porton Biopharma Limited Cell and Gene Therapy Manufacturing Services Product Overview
  10.20.3 Porton Biopharma Limited Cell and Gene Therapy Manufacturing Services Product Market Performance
  10.20.4 Porton Biopharma Limited Business Overview
  10.20.5 Porton Biopharma Limited Recent Developments
10.21 Andelyn Biosciences
  10.21.1 Andelyn Biosciences Cell and Gene Therapy Manufacturing Services Basic Information
  10.21.2 Andelyn Biosciences Cell and Gene Therapy Manufacturing Services Product Overview
  10.21.3 Andelyn Biosciences Cell and Gene Therapy Manufacturing Services Product Market Performance
  10.21.4 Andelyn Biosciences Business Overview
  10.21.5 Andelyn Biosciences Recent Developments
10.22 Commercializing Living Therapies
  10.22.1 Commercializing Living Therapies Cell and Gene Therapy Manufacturing Services Basic Information
  10.22.2 Commercializing Living Therapies Cell and Gene Therapy Manufacturing Services Product Overview
  10.22.3 Commercializing Living Therapies Cell and Gene Therapy Manufacturing Services Product Market Performance
  10.22.4 Commercializing Living Therapies Business Overview
  10.22.5 Commercializing Living Therapies Recent Developments
10.23 Vibalogics
  10.23.1 Vibalogics Cell and Gene Therapy Manufacturing Services Basic Information
  10.23.2 Vibalogics Cell and Gene Therapy Manufacturing Services Product Overview
  10.23.3 Vibalogics Cell and Gene Therapy Manufacturing Services Product Market Performance
  10.23.4 Vibalogics Business Overview
  10.23.5 Vibalogics Recent Developments
10.24 Anemocyte Srl
  10.24.1 Anemocyte Srl Cell and Gene Therapy Manufacturing Services Basic Information
  10.24.2 Anemocyte Srl Cell and Gene Therapy Manufacturing Services Product Overview
  10.24.3 Anemocyte Srl Cell and Gene Therapy Manufacturing Services Product Market Performance
  10.24.4 Anemocyte Srl Business Overview
  10.24.5 Anemocyte Srl Recent Developments
10.25 ElevateBio
  10.25.1 ElevateBio Cell and Gene Therapy Manufacturing Services Basic Information
  10.25.2 ElevateBio Cell and Gene Therapy Manufacturing Services Product Overview
  10.25.3 ElevateBio Cell and Gene Therapy Manufacturing Services Product Market Performance
  10.25.4 ElevateBio Business Overview
  10.25.5 ElevateBio Recent Developments

11 CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET FORECAST BY REGION

11.1 Global Cell and Gene Therapy Manufacturing Services Market Size Forecast
11.2 Global Cell and Gene Therapy Manufacturing Services Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe Cell and Gene Therapy Manufacturing Services Market Size Forecast by Country
  11.2.3 Asia Pacific Cell and Gene Therapy Manufacturing Services Market Size Forecast by Region
  11.2.4 South America Cell and Gene Therapy Manufacturing Services Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Consumption of Cell and Gene Therapy Manufacturing Services by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)

12.1 Global Cell and Gene Therapy Manufacturing Services Market Forecast by Type (2025-2032)
  12.1.1 Global Forecasted Sales of Cell and Gene Therapy Manufacturing Services by Type (2025-2032)
  12.1.2 Global Cell and Gene Therapy Manufacturing Services Market Size Forecast by Type (2025-2032)
  12.1.3 Global Forecasted Price of Cell and Gene Therapy Manufacturing Services by Type (2025-2032)
12.2 Global Cell and Gene Therapy Manufacturing Services Market Forecast by Application (2025-2032)
  12.2.1 Global Cell and Gene Therapy Manufacturing Services Sales (K Units) Forecast by Application
  12.2.2 Global Cell and Gene Therapy Manufacturing Services Market Size (M USD) Forecast by Application (2025-2032)

13 CONCLUSION AND KEY FINDINGS

List Of Tables

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Cell and Gene Therapy Manufacturing Services Market Size Comparison by Region (M USD)
Table 5. Global Cell and Gene Therapy Manufacturing Services Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Cell and Gene Therapy Manufacturing Services Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Cell and Gene Therapy Manufacturing Services Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Cell and Gene Therapy Manufacturing Services Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy Manufacturing Services as of 2022)
Table 10. Global Market Cell and Gene Therapy Manufacturing Services Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Cell and Gene Therapy Manufacturing Services Sales Sites and Area Served
Table 12. Manufacturers Cell and Gene Therapy Manufacturing Services Product Type
Table 13. Global Cell and Gene Therapy Manufacturing Services Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Cell and Gene Therapy Manufacturing Services
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Cell and Gene Therapy Manufacturing Services Market Challenges
Table 22. Global Cell and Gene Therapy Manufacturing Services Sales by Type (K Units)
Table 23. Global Cell and Gene Therapy Manufacturing Services Market Size by Type (M USD)
Table 24. Global Cell and Gene Therapy Manufacturing Services Sales (K Units) by Type (2019-2024)
Table 25. Global Cell and Gene Therapy Manufacturing Services Sales Market Share by Type (2019-2024)
Table 26. Global Cell and Gene Therapy Manufacturing Services Market Size (M USD) by Type (2019-2024)
Table 27. Global Cell and Gene Therapy Manufacturing Services Market Size Share by Type (2019-2024)
Table 28. Global Cell and Gene Therapy Manufacturing Services Price (USD/Unit) by Type (2019-2024)
Table 29. Global Cell and Gene Therapy Manufacturing Services Sales (K Units) by Application
Table 30. Global Cell and Gene Therapy Manufacturing Services Market Size by Application
Table 31. Global Cell and Gene Therapy Manufacturing Services Sales by Application (2019-2024) & (K Units)
Table 32. Global Cell and Gene Therapy Manufacturing Services Sales Market Share by Application (2019-2024)
Table 33. Global Cell and Gene Therapy Manufacturing Services Sales by Application (2019-2024) & (M USD)
Table 34. Global Cell and Gene Therapy Manufacturing Services Market Share by Application (2019-2024)
Table 35. Global Cell and Gene Therapy Manufacturing Services Sales Growth Rate by Application (2019-2024)
Table 36. Global Cell and Gene Therapy Manufacturing Services Sales by Region (2019-2024) & (K Units)
Table 37. Global Cell and Gene Therapy Manufacturing Services Sales Market Share by Region (2019-2024)
Table 38. North America Cell and Gene Therapy Manufacturing Services Sales by Country (2019-2024) & (K Units)
Table 39. Europe Cell and Gene Therapy Manufacturing Services Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Cell and Gene Therapy Manufacturing Services Sales by Region (2019-2024) & (K Units)
Table 41. South America Cell and Gene Therapy Manufacturing Services Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Cell and Gene Therapy Manufacturing Services Sales by Region (2019-2024) & (K Units)
Table 43. Global Cell and Gene Therapy Manufacturing Services Production (K Units) by Region (2019-2024)
Table 44. Global Cell and Gene Therapy Manufacturing Services Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Cell and Gene Therapy Manufacturing Services Revenue Market Share by Region (2019-2024)
Table 46. Global Cell and Gene Therapy Manufacturing Services Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 47. North America Cell and Gene Therapy Manufacturing Services Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 48. Europe Cell and Gene Therapy Manufacturing Services Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 49. Japan Cell and Gene Therapy Manufacturing Services Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 50. China Cell and Gene Therapy Manufacturing Services Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 51. Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services Basic Information
Table 52. Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services Product Overview
Table 53. Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 54. Thermo Fisher Scientific Business Overview
Table 55. Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services SWOT Analysis
Table 56. Thermo Fisher Scientific Recent Developments
Table 57. Merck KGaA Cell and Gene Therapy Manufacturing Services Basic Information
Table 58. Merck KGaA Cell and Gene Therapy Manufacturing Services Product Overview
Table 59. Merck KGaA Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 60. Merck KGaA Business Overview
Table 61. Merck KGaA Cell and Gene Therapy Manufacturing Services SWOT Analysis
Table 62. Merck KGaA Recent Developments
Table 63. Charles River Laboratories Cell and Gene Therapy Manufacturing Services Basic Information
Table 64. Charles River Laboratories Cell and Gene Therapy Manufacturing Services Product Overview
Table 65. Charles River Laboratories Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 66. Charles River Laboratories Cell and Gene Therapy Manufacturing Services SWOT Analysis
Table 67. Charles River Laboratories Business Overview
Table 68. Charles River Laboratories Recent Developments
Table 69. Lonza Cell and Gene Therapy Manufacturing Services Basic Information
Table 70. Lonza Cell and Gene Therapy Manufacturing Services Product Overview
Table 71. Lonza Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 72. Lonza Business Overview
Table 73. Lonza Recent Developments
Table 74. Catalent Cell and Gene Therapy Manufacturing Services Basic Information
Table 75. Catalent Cell and Gene Therapy Manufacturing Services Product Overview
Table 76. Catalent Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 77. Catalent Business Overview
Table 78. Catalent Recent Developments
Table 79. WuXi AppTec Cell and Gene Therapy Manufacturing Services Basic Information
Table 80. WuXi AppTec Cell and Gene Therapy Manufacturing Services Product Overview
Table 81. WuXi AppTec Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 82. WuXi AppTec Business Overview
Table 83. WuXi AppTec Recent Developments
Table 84. Takara Bio Inc Cell and Gene Therapy Manufacturing Services Basic Information
Table 85. Takara Bio Inc Cell and Gene Therapy Manufacturing Services Product Overview
Table 86. Takara Bio Inc Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 87. Takara Bio Inc Business Overview
Table 88. Takara Bio Inc Recent Developments
Table 89. Nikon Corporation Cell and Gene Therapy Manufacturing Services Basic Information
Table 90. Nikon Corporation Cell and Gene Therapy Manufacturing Services Product Overview
Table 91. Nikon Corporation Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 92. Nikon Corporation Business Overview
Table 93. Nikon Corporation Recent Developments
Table 94. FUJIFILM Holdings Corporation Cell and Gene Therapy Manufacturing Services Basic Information
Table 95. FUJIFILM Holdings Corporation Cell and Gene Therapy Manufacturing Services Product Overview
Table 96. FUJIFILM Holdings Corporation Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 97. FUJIFILM Holdings Corporation Business Overview
Table 98. FUJIFILM Holdings Corporation Recent Developments
Table 99. F. Hoffmann-La Roche Cell and Gene Therapy Manufacturing Services Basic Information
Table 100. F. Hoffmann-La Roche Cell and Gene Therapy Manufacturing Services Product Overview
Table 101. F. Hoffmann-La Roche Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 102. F. Hoffmann-La Roche Business Overview
Table 103. F. Hoffmann-La Roche Recent Developments
Table 104. Oxford Biomedica Plc Cell and Gene Therapy Manufacturing Services Basic Information
Table 105. Oxford Biomedica Plc Cell and Gene Therapy Manufacturing Services Product Overview
Table 106. Oxford Biomedica Plc Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 107. Oxford Biomedica Plc Business Overview
Table 108. Oxford Biomedica Plc Recent Developments
Table 109. Cell and Gene Therapy Catapult Cell and Gene Therapy Manufacturing Services Basic Information
Table 110. Cell and Gene Therapy Catapult Cell and Gene Therapy Manufacturing Services Product Overview
Table 111. Cell and Gene Therapy Catapult Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 112. Cell and Gene Therapy Catapult Business Overview
Table 113. Cell and Gene Therapy Catapult Recent Developments
Table 114. The Discovery Labs LLC Cell and Gene Therapy Manufacturing Services Basic Information
Table 115. The Discovery Labs LLC Cell and Gene Therapy Manufacturing Services Product Overview
Table 116. The Discovery Labs LLC Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 117. The Discovery Labs LLC Business Overview
Table 118. The Discovery Labs LLC Recent Developments
Table 119. RoslinCT Cell and Gene Therapy Manufacturing Services Basic Information
Table 120. RoslinCT Cell and Gene Therapy Manufacturing Services Product Overview
Table 121. RoslinCT Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 122. RoslinCT Business Overview
Table 123. RoslinCT Recent Developments
Table 124. JRS PHARMA Cell and Gene Therapy Manufacturing Services Basic Information
Table 125. JRS PHARMA Cell and Gene Therapy Manufacturing Services Product Overview
Table 126. JRS PHARMA Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 127. JRS PHARMA Business Overview
Table 128. JRS PHARMA Recent Developments
Table 129. FinVector Cell and Gene Therapy Manufacturing Services Basic Information
Table 130. FinVector Cell and Gene Therapy Manufacturing Services Product Overview
Table 131. FinVector Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 132. FinVector Business Overview
Table 133. FinVector Recent Developments
Table 134. ABL Cell and Gene Therapy Manufacturing Services Basic Information
Table 135. ABL Cell and Gene Therapy Manufacturing Services Product Overview
Table 136. ABL Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 137. ABL Business Overview
Table 138. ABL Recent Developments
Table 139. Resilience Cell and Gene Therapy Manufacturing Services Basic Information
Table 140. Resilience Cell and Gene Therapy Manufacturing Services Product Overview
Table 141. Resilience Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 142. Resilience Business Overview
Table 143. Resilience Recent Developments
Table 144. BioCentriq Cell and Gene Therapy Manufacturing Services Basic Information
Table 145. BioCentriq Cell and Gene Therapy Manufacturing Services Product Overview
Table 146. BioCentriq Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 147. BioCentriq Business Overview
Table 148. BioCentriq Recent Developments
Table 149. Porton Biopharma Limited Cell and Gene Therapy Manufacturing Services Basic Information
Table 150. Porton Biopharma Limited Cell and Gene Therapy Manufacturing Services Product Overview
Table 151. Porton Biopharma Limited Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 152. Porton Biopharma Limited Business Overview
Table 153. Porton Biopharma Limited Recent Developments
Table 154. Andelyn Biosciences Cell and Gene Therapy Manufacturing Services Basic Information
Table 155. Andelyn Biosciences Cell and Gene Therapy Manufacturing Services Product Overview
Table 156. Andelyn Biosciences Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 157. Andelyn Biosciences Business Overview
Table 158. Andelyn Biosciences Recent Developments
Table 159. Commercializing Living Therapies Cell and Gene Therapy Manufacturing Services Basic Information
Table 160. Commercializing Living Therapies Cell and Gene Therapy Manufacturing Services Product Overview
Table 161. Commercializing Living Therapies Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 162. Commercializing Living Therapies Business Overview
Table 163. Commercializing Living Therapies Recent Developments
Table 164. Vibalogics Cell and Gene Therapy Manufacturing Services Basic Information
Table 165. Vibalogics Cell and Gene Therapy Manufacturing Services Product Overview
Table 166. Vibalogics Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 167. Vibalogics Business Overview
Table 168. Vibalogics Recent Developments
Table 169. Anemocyte Srl Cell and Gene Therapy Manufacturing Services Basic Information
Table 170. Anemocyte Srl Cell and Gene Therapy Manufacturing Services Product Overview
Table 171. Anemocyte Srl Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 172. Anemocyte Srl Business Overview
Table 173. Anemocyte Srl Recent Developments
Table 174. ElevateBio Cell and Gene Therapy Manufacturing Services Basic Information
Table 175. ElevateBio Cell and Gene Therapy Manufacturing Services Product Overview
Table 176. ElevateBio Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 177. ElevateBio Business Overview
Table 178. ElevateBio Recent Developments
Table 179. Global Cell and Gene Therapy Manufacturing Services Sales Forecast by Region (2025-2032) & (K Units)
Table 180. Global Cell and Gene Therapy Manufacturing Services Market Size Forecast by Region (2025-2032) & (M USD)
Table 181. North America Cell and Gene Therapy Manufacturing Services Sales Forecast by Country (2025-2032) & (K Units)
Table 182. North America Cell and Gene Therapy Manufacturing Services Market Size Forecast by Country (2025-2032) & (M USD)
Table 183. Europe Cell and Gene Therapy Manufacturing Services Sales Forecast by Country (2025-2032) & (K Units)
Table 184. Europe Cell and Gene Therapy Manufacturing Services Market Size Forecast by Country (2025-2032) & (M USD)
Table 185. Asia Pacific Cell and Gene Therapy Manufacturing Services Sales Forecast by Region (2025-2032) & (K Units)
Table 186. Asia Pacific Cell and Gene Therapy Manufacturing Services Market Size Forecast by Region (2025-2032) & (M USD)
Table 187. South America Cell and Gene Therapy Manufacturing Services Sales Forecast by Country (2025-2032) & (K Units)
Table 188. South America Cell and Gene Therapy Manufacturing Services Market Size Forecast by Country (2025-2032) & (M USD)
Table 189. Middle East and Africa Cell and Gene Therapy Manufacturing Services Consumption Forecast by Country (2025-2032) & (Units)
Table 190. Middle East and Africa Cell and Gene Therapy Manufacturing Services Market Size Forecast by Country (2025-2032) & (M USD)
Table 191. Global Cell and Gene Therapy Manufacturing Services Sales Forecast by Type (2025-2032) & (K Units)
Table 192. Global Cell and Gene Therapy Manufacturing Services Market Size Forecast by Type (2025-2032) & (M USD)
Table 193. Global Cell and Gene Therapy Manufacturing Services Price Forecast by Type (2025-2032) & (USD/Unit)
Table 194. Global Cell and Gene Therapy Manufacturing Services Sales (K Units) Forecast by Application (2025-2032)
Table 195. Global Cell and Gene Therapy Manufacturing Services Market Size Forecast by Application (2025-2032) & (M USD)

List Of Figures

LIST OF FIGURES

Figure 1. Product Picture of Cell and Gene Therapy Manufacturing Services
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Cell and Gene Therapy Manufacturing Services Market Size (M USD), 2019-2032
Figure 5. Global Cell and Gene Therapy Manufacturing Services Market Size (M USD) (2019-2032)
Figure 6. Global Cell and Gene Therapy Manufacturing Services Sales (K Units) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Cell and Gene Therapy Manufacturing Services Market Size by Country (M USD)
Figure 11. Cell and Gene Therapy Manufacturing Services Sales Share by Manufacturers in 2023
Figure 12. Global Cell and Gene Therapy Manufacturing Services Revenue Share by Manufacturers in 2023
Figure 13. Cell and Gene Therapy Manufacturing Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Cell and Gene Therapy Manufacturing Services Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Cell and Gene Therapy Manufacturing Services Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Cell and Gene Therapy Manufacturing Services Market Share by Type
Figure 18. Sales Market Share of Cell and Gene Therapy Manufacturing Services by Type (2019-2024)
Figure 19. Sales Market Share of Cell and Gene Therapy Manufacturing Services by Type in 2023
Figure 20. Market Size Share of Cell and Gene Therapy Manufacturing Services by Type (2019-2024)
Figure 21. Market Size Market Share of Cell and Gene Therapy Manufacturing Services by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Cell and Gene Therapy Manufacturing Services Market Share by Application
Figure 24. Global Cell and Gene Therapy Manufacturing Services Sales Market Share by Application (2019-2024)
Figure 25. Global Cell and Gene Therapy Manufacturing Services Sales Market Share by Application in 2023
Figure 26. Global Cell and Gene Therapy Manufacturing Services Market Share by Application (2019-2024)
Figure 27. Global Cell and Gene Therapy Manufacturing Services Market Share by Application in 2023
Figure 28. Global Cell and Gene Therapy Manufacturing Services Sales Growth Rate by Application (2019-2024)
Figure 29. Global Cell and Gene Therapy Manufacturing Services Sales Market Share by Region (2019-2024)
Figure 30. North America Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Cell and Gene Therapy Manufacturing Services Sales Market Share by Country in 2023
Figure 32. U.S. Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Cell and Gene Therapy Manufacturing Services Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Cell and Gene Therapy Manufacturing Services Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Cell and Gene Therapy Manufacturing Services Sales Market Share by Country in 2023
Figure 37. Germany Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Cell and Gene Therapy Manufacturing Services Sales Market Share by Region in 2023
Figure 44. China Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (K Units)
Figure 50. South America Cell and Gene Therapy Manufacturing Services Sales Market Share by Country in 2023
Figure 51. Brazil Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Cell and Gene Therapy Manufacturing Services Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Cell and Gene Therapy Manufacturing Services Production Market Share by Region (2019-2024)
Figure 62. North America Cell and Gene Therapy Manufacturing Services Production (K Units) Growth Rate (2019-2024)
Figure 63. Europe Cell and Gene Therapy Manufacturing Services Production (K Units) Growth Rate (2019-2024)
Figure 64. Japan Cell and Gene Therapy Manufacturing Services Production (K Units) Growth Rate (2019-2024)
Figure 65. China Cell and Gene Therapy Manufacturing Services Production (K Units) Growth Rate (2019-2024)
Figure 66. Global Cell and Gene Therapy Manufacturing Services Sales Forecast by Volume (2019-2032) & (K Units)
Figure 67. Global Cell and Gene Therapy Manufacturing Services Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Cell and Gene Therapy Manufacturing Services Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Cell and Gene Therapy Manufacturing Services Market Share Forecast by Type (2025-2032)
Figure 70. Global Cell and Gene Therapy Manufacturing Services Sales Forecast by Application (2025-2032)
Figure 71. Global Cell and Gene Therapy Manufacturing Services Market Share Forecast by Application (2025-2032)